SCHEMBL14972675

SCHEMBL14972675

c1cc(-c2ccc(-c3ccncc3)c3nsnc23)ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.46
▸ LMNA P02545 1/20 0.46
▸ NOTUM Q6P988 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ MAPK14 Q16539 4/20 0.36
▸ DDAH1 O94760 1/20 0.35
▸ NOS1 P29475 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29079180 0.88 MAPT (0.36) MAPTLMNANOTUMNPC1RAB9A
SCHEMBL26500109 0.80 PRF1 (0.43) MAPTLMNANOTUMKDM4ECYP1A2
SCHEMBL30599258 0.80 KDM4E (0.48) MAPTLMNANOTUMNPC1RAB9A
SCHEMBL19219070 0.77 MAPT (0.46) MAPTLMNANOTUMNPC1RAB9A
SCHEMBL862821 0.74 COMT (0.40) MAPTLMNANOTUMNPC1RAB9A
SCHEMBL21915668 0.74 CYP3A4 (0.43) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL21364460 0.74 MEN1 (0.39) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL14806811 0.74 MAPK14 (0.39) LMNANPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL14416272 0.74 ESR1 (0.48) MAPTNPC1RAB9ASMN1; SMN2TP53
SCHEMBL714013 0.74 ALDH1A1 (0.41) MAPTLMNANOTUMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2597127-B1 Electrochromic compound, electrochromic composition, and display device RICOH CO LTD (JP) 2014-03-19 — — EP disclosed
US-8625186-B2 Electrochromic compound, electrochromic composition, and display device RICOH COMPANY, LTD. (JP) 2014-01-07 — — US disclosed
US-8625186-B2 Electrochromic compound, electrochromic composition, and display device RICOH COMPANY, LTD. (JP) 2014-01-07 — — US disclosed
US-8625186-B2 Electrochromic compound, electrochromic composition, and display device RICOH COMPANY, LTD. (JP) 2014-01-07 — — US disclosed
US-20130135703-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY DEVICE RICOH COMPANY, LTD. (JP) 2013-05-30 — — US disclosed
US-20130135703-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY DEVICE RICOH COMPANY, LTD. (JP) 2013-05-30 — — US disclosed
US-20130135703-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY DEVICE RICOH COMPANY, LTD. (JP) 2013-05-30 — — US disclosed
EP-2597127-A1 Electrochromic compound, electrochromic composition, and display device Ricoh Company, Ltd. (JP) 2013-05-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130135703-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY DEVICE H1-10, H1-0, HRH3 MAPT 4310/4885LMNA 3685/4885NOTUM 4280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback